Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | K. Patel | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | C. Dinardo | R. Kanagal-Shamanna | N. Pemmaraju | N. Short | J. Lamba | I. Papageorgiou | Guillaume Richard-Carpentier